Why folic acid doesn’t work
for nearly half the population.

What is the MTHFR gene — in plain language

MTHFR stands for methylenetetrahydrofolate reductase — one of the most important enzymes in your body’s folate metabolism pathway. Its job is simple but critical: it converts synthetic folic acid (the form found in most supplements and fortified foods) into active folate (Vitamin B9) — a form called L-5-methyltetrahydrofolate, or L-5-MTHF — that your cells can actually absorb and use.

The MTHFR gene gives your body the instructions to produce this enzyme. When that gene has a common variant (sometimes called a “mutation” or “polymorphism”), the enzyme it produces doesn’t work at full efficiency. The result: synthetic folic acid piles up in your bloodstream, largely unconverted, while your cells remain quietly deficient in the folate (Vitamin B9) they were trying to get.

The two most studied variants are MTHFR C677T and MTHFR A1298C. C677T is the more clinically significant: in people who inherit one copy (heterozygous), it reduces MTHFR enzyme efficiency by roughly 35%. In people who inherit two copies (homozygous), efficiency drops by 70%. These are not rare edge cases — they affect a significant slice of every population on earth, including India.

Why this matters more in India specifically

India sits at a particularly difficult intersection of three compounding factors:

No mandatory folic acid fortification. Countries like the USA, Canada, and much of Europe mandatorily add folic acid to flour and grain products. India has no such policy — meaning dietary folate (Vitamin B9) intake is lower from the start.

Widespread vegetarian diets. Natural food folate comes primarily from leafy greens, lentils, and legumes — all well-represented in Indian cooking. However, Vitamin B12 (which works hand-in-hand with folate in the methylation cycle) is almost exclusively from animal sources. For vegetarians, the double burden of inadequate B12 and MTHFR-impaired folate metabolism creates a compound bottleneck that neither problem alone would cause.

High prevalence of the A1298C variant in Indian populations. Research published in the Journal of Human Genetics (PMID: 16244782) found that the MTHFR A1298C polymorphism occurs at notably high frequency in Indian populations (minor allele frequency of 0.44), and is significantly associated with elevated homocysteine — an amino acid that accumulates when the folate-B12-methylation cycle is disrupted, and which is linked to cardiovascular risk, cognitive decline, and neural tube defects in pregnancy.

The conversion problem: folic acid vs. active folate

Most people assume that if their multivitamin says “400 µg folic acid” on the label, their body is getting 400 µg of usable folate. This is incorrect — and understanding why is the key to understanding MTHFR.

Folic Acid vs. Quatrefolic® Active Methylfolate — a direct comparison

The absorption block checklist — could MTHFR affect you?

There’s no reliable way to know you have an MTHFR variant without a blood or genetic test. However, certain symptom patterns are consistently reported by people who later discover they carry MTHFR variants. If several of these resonate — and you’ve been supplementing with standard folic acid without noticing improvement — it’s worth discussing MTHFR testing with your doctor.

What good supplementation actually looks like

The solution to MTHFR-related folate absorption problems is not “more folic acid.” It’s the right form — one that doesn’t require your MTHFR enzyme to work.

Active methylfolate (L-5-MTHF) is the end-stage form of folate (Vitamin B9) that cells can use immediately. It doesn’t wait for enzyme conversion. It doesn’t accumulate as UMFA. It crosses the blood-brain barrier directly, supporting serotonin synthesis, DNA methylation, and homocysteine metabolism regardless of what your MTHFR gene looks like.